Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 15th, there was short interest totaling 3,504 shares, a decline of 33.2% from the December 31st total of 5,247 shares. Based on an average trading volume of 881 shares, the days-to-cover ratio is currently 4.0 days. Based on an average trading volume of 881 shares, the days-to-cover ratio is currently 4.0 days.
Biofrontera Stock Up 0.2%
Shares of NASDAQ BFRIW traded up $0.00 during trading on Friday, hitting $0.05. 100 shares of the company were exchanged, compared to its average volume of 1,867. The company has a fifty day moving average price of $0.06 and a 200-day moving average price of $0.10. Biofrontera has a 12-month low of $0.03 and a 12-month high of $0.28.
About Biofrontera
Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.
The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.
Featured Stories
- Five stocks we like better than Biofrontera
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Gold’s getting scarce.
- Trump’s Final Shocking Act Begins February 24
- The Number One Way to Play Gold
- NEW: Gold makes history
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
